Mendelian Randomization as an Approach to Assess Causality Using Observational Data

Klungel, 2004, Methods to assess intended effects of drug treatment in observational studies are reviewed., J Clin Epidemiol, 57, 1223, 10.1016/j.jclinepi.2004.03.011

Lawlor, 2008, Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology., Stat Med, 27, 1133, 10.1002/sim.3034

Evans, 2015, Mendelian randomization: New applications in the coming age of hypothesis-free causality., Annu Rev Genomics Hum Genet, 16, 327, 10.1146/annurev-genom-090314-050016

Weed, 1998, Biologic plausibility in causal inference: Current method and practice., Am J Epidemiol, 147, 415, 10.1093/oxfordjournals.aje.a009466

Jansen, 2014, Mendelian randomization studies in coronary artery disease., Eur Heart J, 35, 1917, 10.1093/eurheartj/ehu208

Greenland, 2000, An introduction to instrumental variables for epidemiologists., Int J Epidemiol, 29, 722, 10.1093/ije/29.4.722

Thomas, 2004, Commentary: The concept of ‘Mendelian randomization’., Int J Epidemiol, 33, 21, 10.1093/ije/dyh048

Bennett, 2010, An introduction to instrumental variables analysis: Part 1., Neuroepidemiology, 35, 237, 10.1159/000319455

Taylor, 2014, Mendelian randomization in health research: Using appropriate genetic variants and avoiding biased estimates., Econ Hum Biol, 13, 99, 10.1016/j.ehb.2013.12.002

Bennett, 2010, An introduction to instrumental variables--part 2: Mendelian randomisation., Neuroepidemiology, 35, 307, 10.1159/000321179

Burgess, 2015, Mendelian randomization: Where are we now and where are we going?, Int J Epidemiol, 44, 379, 10.1093/ije/dyv108

Verduijn, 2010, Mendelian randomization: Use of genetics to enable causal inference in observational studies., Nephrol Dial Transplant, 25, 1394, 10.1093/ndt/gfq098

Smith, 2014, Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis., JAMA, 312, 1764, 10.1001/jama.2014.13959

Davey Smith, 2014, Mendelian randomization: Genetic anchors for causal inference in epidemiological studies., Hum Mol Genet, 23, R89, 10.1093/hmg/ddu328

Palmer, 2012, Using multiple genetic variants as instrumental variables for modifiable risk factors., Stat Methods Med Res, 21, 223, 10.1177/0962280210394459

Burgess, 2013, Mendelian randomization analysis with multiple genetic variants using summarized data., Genet Epidemiol, 37, 658, 10.1002/gepi.21758

Davies, 2015, The many weak instruments problem and Mendelian randomization., Stat Med, 34, 454, 10.1002/sim.6358

Davies, 2013, Issues in the reporting and conduct of instrumental variable studies: A systematic review., Epidemiology, 24, 363, 10.1097/EDE.0b013e31828abafb

Swanson, 2013, Commentary: How to report instrumental variable analyses (suggestions welcome)., Epidemiology, 24, 370, 10.1097/EDE.0b013e31828d0590

Hernán, 2006, Instruments for causal inference: An epidemiologist’s dream?, Epidemiology, 17, 360, 10.1097/01.ede.0000222409.00878.37

Del Greco, 2015, Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome., Stat Med, 34, 2926, 10.1002/sim.6522

Martens, 2006, Instrumental variables: Application and limitations., Epidemiology, 17, 260, 10.1097/01.ede.0000215160.88317.cb

Didelez, 2010, Assumptions of IV methods for observational epidemiology., Stat Sci, 25, 22, 10.1214/09-STS316

Clarke, 2012, Instrumental variable estimators for binary outcomes., J Am Stat Assoc, 107, 1638, 10.1080/01621459.2012.734171

Burgess, A review of instrumental variable estimators for Mendelian randomization [published online ahead of print August 17, 2015]., Stat Methods Med Res

Palmer, 2008, Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses., Int J Epidemiol, 37, 1161, 10.1093/ije/dyn080

Palmer, 2011, Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses., Am J Epidemiol, 173, 1392, 10.1093/aje/kwr026

Vuistiner, 2012, A comparison of three methods of Mendelian randomization when the genetic instrument, the risk factor and the outcome are all binary., PLoS One, 7, e35951, 10.1371/journal.pone.0035951

Harbord, 2013, Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies., Stat Med, 32, 1246, 10.1002/sim.5659

Boef, 2015, Mendelian randomization studies: A review of the approaches used and the quality of reporting., Int J Epidemiol, 44, 496, 10.1093/ije/dyv071

Freathy, 2008, Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI., Diabetes, 57, 1419, 10.2337/db07-1466

Brion, 2014, Beyond the single SNP: Emerging developments in mendelian randomization in the “omics” era., Curr Epidemiol Rep, 1, 228, 10.1007/s40471-014-0024-2

Inoue, 2010, Two-sample instrumental variables estimators., Rev Econ Stat, 92, 557, 10.1162/REST_a_00011

Pierce, 2013, Efficient design for Mendelian randomization studies: Subsample and 2-sample instrumental variable estimators., Am J Epidemiol, 178, 1177, 10.1093/aje/kwt084

Welsh, 2010, Unraveling the directional link between adiposity and inflammation: A bidirectional Mendelian randomization approach., J Clin Endocrinol Metab, 95, 93, 10.1210/jc.2009-1064

Palmer, 2013, Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts., BMJ, 347, f4262, 10.1136/bmj.f4262

Burgess, 2015, Network Mendelian randomization: Using genetic variants as instrumental variables to investigate mediation in causal pathways., Int J Epidemiol, 44, 484, 10.1093/ije/dyu176

Relton, 2012, Two-step epigenetic Mendelian randomization: A strategy for establishing the causal role of epigenetic processes in pathways to disease., Int J Epidemiol, 41, 161, 10.1093/ije/dyr233

Varbo, 2015, Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease., Circ Res, 116, 665, 10.1161/CIRCRESAHA.116.304846

Evans, 2013, Mining the human phenome using allelic scores that index biological intermediates., PLoS Genet, 9, e1003919, 10.1371/journal.pgen.1003919

Linsel-Nitschke, 2008, Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study., PLoS One, 3, e2986, 10.1371/journal.pone.0002986

Ference, 2012, Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: A Mendelian randomization analysis., J Am Coll Cardiol, 60, 2631, 10.1016/j.jacc.2012.09.017

Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study., Lancet, 380, 572, 10.1016/S0140-6736(12)60312-2

Burkhardt, 2008, Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13., Arterioscler Thromb Vasc Biol, 28, 2078, 10.1161/ATVBAHA.108.172288

Talmud, 2009, Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip., Am J Hum Genet, 85, 628, 10.1016/j.ajhg.2009.10.014

McKenney, 2015, Understanding PCSK9 and anti-PCSK9 therapies., J Clin Lipidol, 9, 170, 10.1016/j.jacl.2015.01.001

Zacho, 2008, Genetically elevated C-reactive protein and ischemic vascular disease., N Engl J Med, 359, 1897, 10.1056/NEJMoa0707402

Elliott, 2009, Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease., JAMA, 302, 37, 10.1001/jama.2009.954

Wensley, 2011, Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data., BMJ, 342, d548, 10.1136/bmj.d548

VanderWeele, 2014, Methodological challenges in mendelian randomization., Epidemiology, 25, 427, 10.1097/EDE.0000000000000081

Swerdlow, 2015, HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials., Lancet, 385, 351, 10.1016/S0140-6736(14)61183-1

Testa, 2014, Association of a polymorphism in a gene encoding a urate transporter with CKD progression., Clin J Am Soc Nephrol, 9, 1059, 10.2215/CJN.11041013

Hughes, 2014, Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function., Kidney Int, 85, 344, 10.1038/ki.2013.353

Yang, 2010, Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors., Circ Cardiovasc Genet, 3, 523, 10.1161/CIRCGENETICS.109.934455

Greenberg, 2015, Plasma urate and risk of a hospital stay with AKI: The Atherosclerosis Risk in Communities Study., Clin J Am Soc Nephrol, 10, 776, 10.2215/CJN.05870614

Del Greco, Serum iron level and kidney function: A Mendelian randomization study [published online ahead of print June 2, 2016]., Nephrol Dial Transplant

Benyamin, 2014, Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis., Nat Commun, 5, 4926, 10.1038/ncomms5926

Pattaro, 2012, Genome-wide association and functional follow-up reveals new loci for kidney function., PLoS Genet, 8, e1002584, 10.1371/journal.pgen.1002584

Panduru, 2015, Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: A likely causal link in patients with type 1 diabetes., Diabetes Care, 38, 1130, 10.2337/dc14-2330

Todd, 2015, Genetic evidence for a causal role of obesity in diabetic kidney disease., Diabetes, 64, 4238, 10.2337/db15-0254

Verduijn, 2011, Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach., Nephrol Dial Transplant, 26, 239, 10.1093/ndt/gfq402

Zoccali, 2006, Mendelian randomization: A new approach to studying epidemiology in ESRD., Am J Kidney Dis, 47, 332, 10.1053/j.ajkd.2005.10.027

Liu, 2004, Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition., JAMA, 291, 451, 10.1001/jama.291.4.451

Boef, 2015, Mendelian randomization studies in the elderly., Epidemiology, 26, e15, 10.1097/EDE.0000000000000243

Böger, 2011, CUBN is a gene locus for albuminuria., J Am Soc Nephrol, 22, 555, 10.1681/ASN.2010060598

Köttgen, 2010, New loci associated with kidney function and chronic kidney disease., Nat Genet, 42, 376, 10.1038/ng.568

Pattaro, 2016, Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function., Nat Commun, 7, 10023, 10.1038/ncomms10023

Okada, 2012, Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations., Nat Genet, 44, 904, 10.1038/ng.2352

Gharavi, 2011, Genome-wide association study identifies susceptibility loci for IgA nephropathy., Nat Genet, 43, 321, 10.1038/ng.787

Yu, 2011, A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy., Nat Genet, 44, 178, 10.1038/ng.1047

Kiryluk, 2014, Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens., Nat Genet, 46, 1187, 10.1038/ng.3118

Köttgen, 2013, Genome-wide association analyses identify 18 new loci associated with serum urate concentrations., Nat Genet, 45, 145, 10.1038/ng.2500

Sandholm, 2013, Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes., J Am Soc Nephrol, 24, 1537, 10.1681/ASN.2012111122

Iyengar, 2015, Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney disease: Family Investigation of Nephropathy and Diabetes (FIND)., PLoS Genet, 11, e1005352, 10.1371/journal.pgen.1005352

Olden, 2013, Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: The CKDGen consortium., Am J Kidney Dis, 61, 889, 10.1053/j.ajkd.2012.12.024

Matsushita, 2010, Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis., Lancet, 375, 2073, 10.1016/S0140-6736(10)60674-5

Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects., Biometrika, 70, 41, 10.1093/biomet/70.1.41

D’Agostino, 1998, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group., Stat Med, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B

Robins, 2000, Marginal structural models and causal inference in epidemiology., Epidemiology, 11, 550, 10.1097/00001648-200009000-00011

Joffe, 2004, Model selection, confounder control, and marginal structural models: Review and new applications., Am Stat, 58, 272, 10.1198/000313004X5824

Brion, 2013, Calculating statistical power in Mendelian randomization studies., Int J Epidemiol, 42, 1497, 10.1093/ije/dyt179

Freeman, 2013, Power and sample size calculations for Mendelian randomization studies using one genetic instrument., Int J Epidemiol, 42, 1157, 10.1093/ije/dyt110

Burgess, 2014, Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome., Int J Epidemiol, 43, 922, 10.1093/ije/dyu005

Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins., Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1

Millard, 2015, MR-PheWAS: Hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization., Sci Rep, 5, 16645, 10.1038/srep16645

Burgess, 2011, Avoiding bias from weak instruments in Mendelian randomization studies., Int J Epidemiol, 40, 755, 10.1093/ije/dyr036

Burgess, 2013, Use of allele scores as instrumental variables for Mendelian randomization., Int J Epidemiol, 42, 1134, 10.1093/ije/dyt093

Bowden, 2015, Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression., Int J Epidemiol, 44, 512, 10.1093/ije/dyv080

Mokry, 2015, Mendelian randomisation applied to drug development in cardiovascular disease: A review., J Med Genet, 52, 71, 10.1136/jmedgenet-2014-102438

Osier, 2002, A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity., Am J Hum Genet, 71, 84, 10.1086/341290

Lewis, 2005, Alcohol, ALDH2, and esophageal cancer: A meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach., Cancer Epidemiol Biomarkers Prev, 14, 1967, 10.1158/1055-9965.EPI-05-0196

Smith, 2010, Mendelian randomization for strengthening causal inference in observational studies: Application to gene × environment interactions., Perspect Psychol Sci, 5, 527, 10.1177/1745691610383505